Conditions: Atrial Fibrillation Heart Failure
Keywords: atrial fibrillation heart failure ranolazine cardioversion persistent AF paroxysmal AF
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 8
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy of ranolazine in the prevention of recurrent atrial fibrillation in post-cardioversion patients with heart failure and preserved ejection fraction.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ranolazine intervention 2: Placebo
Intervention descriptions: intervention 1: Patients will take ranolazine 1000 mg tablets twice daily intervention 2: Placebo pill manufactured to mimic ranolazine 1000 mg tablets. Patients will be instructed to take two pills a day.

Protocol document: